Dextromethorphan (DXM)

What Is Dextromethorphan (DXM)?

Dextromethorphan (DXM) is a non-opioid cough suppressant available over-the-counter in numerous products including Robitussin, NyQuil, Coricidin, and generic cough syrups and tablets. At therapeutic doses (15-30 mg every 4-6 hours), DXM suppresses the cough reflex by acting on the brainstem cough center.

However, when taken in doses 10-50 times higher than therapeutic recommendations, DXM produces dissociative and hallucinogenic effects through its action as a sigma-1 receptor agonist and N-methyl-D-aspartate (NMDA) receptor antagonist. This misuse, commonly called "robotripping," has become a significant public health concern among adolescents and young adults.

History of DXM Abuse

DXM abuse has been documented since the 1970s but became most prevalent among teenagers around 2000-2006. Peak abuse in the mid-2000s resulted in 34,755 single-substance DXM exposures reported to poison centers in 2006. Though somewhat less prevalent than peak years, DXM abuse remains a consistent concern, with approximately 6,000 emergency department visits annually in the United States related to DXM toxicity or overdose.

The availability of DXM products at any store without age restriction makes it one of the most accessible substances for youth experimentation. Over the past 15 years, poison center calls related to DXM have increased steadily since 2006, indicating a sustained abuse pattern.

DXM Products and Formulations

DXM is found in hundreds of OTC products. Single-ingredient DXM products are preferred by abusers because they avoid additional harmful ingredients. However, many products combine DXM with other active ingredients that increase toxicity at high doses.

Product Type	Examples	Risks with High Doses
DXM only (safer for abusers)	Robitussin Cough (liquid), some tablets	Dissociation, hallucinations, seizures, serotonin syndrome
DXM + guaifenesin	Robitussin DM, Mucinex DM	GI distress, nausea, vomiting, abdominal pain (guaifenesin acts as expectorant)
DXM + acetaminophen	Robitussin CF, Coricidin HBP Cough	Severe liver damage; acetaminophen overdose causes acute liver failure
DXM + antihistamine	NyQuil, Drixoral, Theraflu	Extreme sedation, respiratory depression, anticholinergic effects
DXM + decongestant	Coricidin, Actifed	Severe hypertension, rapid heart rate, chest pain, stroke

DXM Plateaus - Dose Effects

DXM produces four distinct stages of intoxication called "plateaus," each tied to specific dose ranges. Understanding these plateaus is critical because each level carries progressively greater health risks.

First Plateau (100-200 mg)

At 100-200 mg, effects are similar to consuming 2-3 drinks of alcohol. Users report mild stimulation, euphoria, increased energy, enhanced sociability, and talkativeness. Physical effects include mild pupil dilation, increased heart rate, and slight blood pressure elevation. The experience feels pleasant and energizing rather than sedating.

Second Plateau (200-400 mg)

At 200-400 mg, intoxication intensifies considerably. Users experience pronounced euphoria, visual hallucinations (colors appear brighter, patterns emerge), auditory distortions, and loss of motor coordination. Most users report this plateau as enjoyable but recognize significant impairment. Nausea, dizziness, and difficulty speaking become noticeable. Heart rate and blood pressure continue to rise. This dose range creates the most sought-after recreational experience.

Third Plateau (400-600 mg)

At 400-600 mg, users become nearly incapacitated. Profound dissociation develops - the user feels separated from their body and surroundings. Time perception is severely distorted. Complex hallucinations occur (seeing people or creatures, elaborate dreamlike scenes). Users often cannot stand or walk without assistance. Speech is incoherent. Confusion, disorientation, and panic sometimes occur. Medical emergencies are increasingly likely at this dose.

Fourth Plateau (600-1,500+ mg)

At 600-1,500+ mg or higher, users enter an extreme state of dissociation bordering on coma. The experience is described as completely detached from reality - a "trance-like" state with out-of-body sensations. Severe hallucinations, delirium, and paranoia are common. Users lose awareness of surroundings and may not remember the experience afterward. Dangerous behaviors occur including aggression, violence, and self-injury due to lack of pain perception and impaired judgment. Medical complications including seizures, severe respiratory depression, dangerous heart rhythms, and death are serious risks at this dose.

Short-Term Effects of DXM Abuse

• Dissociation and depersonalization - Feeling separated from one's body and surroundings; out-of-body experiences at higher doses
• Visual and auditory hallucinations - Seeing colors, patterns, people, or creatures; hearing voices or music; visual distortions intensifying with dose
• Euphoria and mood elevation - Pleasure and heightened mood, particularly at second plateau doses
• Impaired motor coordination - Loss of balance, difficulty walking or standing, poor fine motor control
• Cognitive impairment - Confusion, difficulty concentrating, poor memory formation, decreased judgment
• Nausea and vomiting - Gastrointestinal distress worsens at higher doses, especially with products containing guaifenesin or acetaminophen
• Rapid heart rate and elevated blood pressure - Tachycardia and hypertension increasing with dose
• Dilated pupils - Persistent pupil dilation occurs at abuse doses
• Sedation and drowsiness - Fatigue and difficulty staying alert, intensifying at higher doses
• Itching and skin flushing - Histamine release causes uncomfortable itching, particularly with products containing antihistamines

Long-Term Effects of DXM Abuse

Physical Effects

• Respiratory depression - Chronic use reduces breathing rate and depth, increasing oxygen deprivation risk; respiratory arrest possible at high doses or with other CNS depressants
• Cardiovascular damage - Chronic elevated heart rate and blood pressure; increased risk of heart attack, stroke, and dangerous arrhythmias
• Liver damage - Particularly severe with formulations containing acetaminophen; chronic acetaminophen exposure from DXM products causes cirrhosis and acute liver failure
• Kidney damage - Chronic abuse damages kidneys; risk increases with dehydration common during abuse episodes
• Neurological damage - NMDA receptor antagonism at high chronic doses may cause neurotoxicity; impaired cognition and memory loss persist even after use stops
• Gastrointestinal problems - Chronic nausea, vomiting, abdominal pain, ulcers, and GI bleeding; guaifenesin-containing products compound these effects
• Dental problems - Poor oral hygiene from neglect; acidic cough syrup products cause tooth decay and enamel erosion
• Weight loss and malnutrition - Loss of appetite, irregular eating, poor nutrition from prioritizing drug use

Psychological Effects

• Psychological dependence - Cravings develop; difficulty stopping use despite wanting to; compulsive redosing
• Depression and anxiety - Mood disturbances both during intoxication and between uses; worsening anxiety upon cessation
• Cognitive impairment - Memory loss, difficulty concentrating, poor judgment, reduced executive function
• Persistent dissociation - Some users develop prolonged dissociative symptoms that continue between doses, affecting daily functioning
• Psychosis and paranoia - Paranoid ideation, false beliefs, and hallucinations may persist or recur unpredictably
• Sleep disturbances - Insomnia or opposite - excessive sleeping; disrupted sleep architecture
• Social withdrawal - Loss of interest in friends, school, work, and activities; isolation increases as abuse becomes central to life

Serotonin Syndrome - Critical Drug Interaction

Serotonin syndrome is a potentially life-threatening condition that develops when DXM is mixed with certain medications. DXM acts as a serotonin reuptake inhibitor at abuse doses, and combining it with other serotonergic drugs floods the brain with serotonin.

High-risk combinations include DXM with SSRIs (selective serotonin reuptake inhibitors like sertraline, fluoxetine, paroxetine), SNRIs (serotonin-norepinephrine reuptake inhibitors like venlafaxine), MAOIs (monoamine oxidase inhibitors), tramadol, or other drugs that increase serotonin.

Serotonin syndrome symptoms include agitation, confusion, rapid heart rate, high blood pressure, elevated body temperature, muscle rigidity, tremors, and severe headache. Severe cases involve hyperthermia (body temperature over 106 F), seizures, rhabdomyolysis (muscle breakdown), kidney failure, and death.

DXM Overdose and Toxicity

DXM overdose becomes a medical emergency at doses generally above 400-600 mg, though individual sensitivity varies. Overdose presents with altered mental status, respiratory depression, seizures, severe hypertension or hypotension, irregular heart rhythms, hyperthermia, and potential cardiovascular collapse.

Medical complications from severe overdose include aspiration of vomit (particularly when sedated), loss of protective airway reflexes, respiratory failure requiring ventilation, and rhabdomyolysis from muscle rigidity and hyperthermia leading to acute kidney injury.

Overdose Deaths & Emergency Department Statistics

Time Period/Metric	Data	Source
Annual ER visits (current)	6,000+ emergency department visits per year	National Capital Poison Center, DEA
Peak year (2006)	34,755 single-substance DXM exposures reported to poison centers	Poison Control System
Age of abusers (2024)	74.5% of DXM abuse cases involved individuals aged 9-17; median age 16	California Poison Control System
Documented fatal cases	Multiple deaths documented in medical literature from single DXM overdoses and combinations with other drugs	PubMed, Journal of Analytical Toxicology

The DEA officially lists dextromethorphan as a "drug of concern" due to its abuse potential and the significant public health burden. While specific national mortality data is limited, the high volume of emergency department visits and poison control calls demonstrates the extent of abuse and associated harms.

Signs of DXM Addiction

• Regular high-dose use - Intentionally taking DXM in doses well above therapeutic recommendations; purchasing large quantities
• Preoccupation with obtaining and using - Spending significant time and money obtaining products; visiting multiple stores to avoid detection
• Failed attempts to reduce use - Repeated unsuccessful attempts to cut back despite wanting to; inability to stick to limits
• Neglect of responsibilities - Missing school or work; grades declining; household or family responsibilities neglected
• Continued use despite negative consequences - Persisting despite overdose experiences, emergency visits, or interpersonal problems
• Tolerance development - Needing increasingly higher doses to achieve the same effects
• Withdrawal symptoms upon cessation - Anxiety, depression, insomnia, irritability, physical discomfort when unable to use
• Intense cravings - Preoccupation with the drug; strong desire to use when cravings occur
• Deceptive behavior - Lying about use, hiding products, defensive behavior when confronted
• Social isolation - Withdrawing from friends and family; spending time only with other users
• Physical signs - Glazed eyes, strange behavior, unusual odor from cough syrup products, weight loss

DXM Withdrawal Timeline

Unlike opioid withdrawal, DXM withdrawal is not typically medically dangerous but is psychologically difficult. Symptoms peak around days 3-7 and gradually improve over 2-3 weeks, though psychological symptoms may persist longer.

Phase	Timeframe	Symptoms
Early withdrawal	24-48 hours after last use	Anxiety, irritability, insomnia, restlessness, increased appetite, cravings begin
Peak withdrawal	Days 3-7	Severe depression, anxiety, muscle aches, sweating, intense cravings, nausea, vomiting, cold flashes, diarrhea, headaches, difficulty concentrating
Acute phase resolution	Week 2-3	Physical symptoms improve; psychological symptoms persist - depression, anxiety, sleep problems, lingering cravings
PAWS (Post-Acute Withdrawal)	Weeks 3 onward; can persist months to years	Anhedonia (inability to feel pleasure), low mood, cravings, irritability, mild anxiety, difficulty sleeping; symptoms wax and wane

The average acute DXM withdrawal lasts about 14 days, but post-acute withdrawal syndrome (PAWS) may persist for months or longer. This prolonged phase involves subtle but persistent psychological symptoms that can trigger relapse if not managed with therapy and support.

Treatment Options

Medical Detoxification

While DXM withdrawal is not medically life-threatening like alcohol or benzodiazepine withdrawal, medical supervision is still beneficial. Doctors can monitor for complications, address specific symptoms, and provide medications to support comfort during the acute phase.

Medication Support

There is no specific medication for DXM dependence equivalent to buprenorphine for opioids. However, medications can address individual withdrawal symptoms:

• Sleep aids - Melatonin, trazodone, or other sleep medications for insomnia
• Anti-anxiety medications - Benzodiazepines (short-term only) or buspirone for anxiety; must be monitored carefully due to abuse potential
• Antidepressants - SSRIs help with depression and may reduce cravings; takes 2-4 weeks to be effective
• Anti-nausea medications - Ondansetron or other antiemetics for nausea and vomiting
• Pain management - Over-the-counter NSAIDs or acetaminophen (carefully, given potential for abuse of acetaminophen-containing products) for muscle aches

Gradual Tapering

A gradual tapering schedule is safer than quitting abruptly. Reduction by 10-25% every few days eases withdrawal symptoms while maintaining stable function. This approach allows the brain to gradually readjust serotonin levels.

Behavioral Therapies

Individual therapy addresses underlying causes of abuse, teaches coping strategies, and identifies and manages triggers. Cognitive-behavioral therapy (CBT) is particularly effective for identifying thought patterns and environmental triggers that lead to use.

Group therapy and peer support groups like Narcotics Anonymous or SMART Recovery provide accountability, connection with others in recovery, and evidence-based relapse prevention strategies. Family therapy helps repair relationships damaged by drug use and creates a supportive home environment.

Inpatient and Outpatient Programs

For severe DXM addiction or when underlying mental health conditions exist, residential treatment programs provide intensive structure, therapy, and peer support. Outpatient programs allow individuals to receive treatment while maintaining work or school, though they require strong motivation and family support.

DXM Abuse Prevention

Parents, teachers, and healthcare providers should be aware that DXM abuse is easy to conceal since products are legal, affordable, and widely available. Warning signs include sudden interest in cough medicine products, purchasing in unusual quantities, secretive behavior, changes in academic or work performance, and sudden mood or personality changes.

Education about DXM plateaus and risks, especially targeting adolescents, is critical. Many teens are unaware that DXM at high doses carries overdose and death risks, and that the effect plateaus lead to dramatically increasing dangers at higher doses.

Emergency Resources

Resource	Contact	Services
Emergency Services	911	Call for seizures, respiratory distress, chest pain, confusion, altered mental status, or overdose
Poison Control	1-800-222-1222 (24/7)	Immediate guidance on overdose, toxic exposures, toxicity assessment
SAMHSA National Helpline	1-800-662-4357 (free, confidential, 24/7)	Substance abuse treatment referrals, addiction counseling, resource information
988 Suicide and Crisis Lifeline	988 or text 988 (24/7)	Crisis support, mental health emergencies, suicidal thoughts during withdrawal
Narcotics Anonymous	NA.org (find local meetings)	Free peer support, 12-step recovery meetings available worldwide
SMART Recovery	smartrecovery.org (find local meetings)	Science-based recovery support, alternative to 12-step programs

Frequently Asked Questions

What is robotripping?

Robotripping refers to intentionally misusing dextromethorphan (DXM) in doses far exceeding therapeutic recommendations to achieve dissociative and hallucinogenic effects. The term comes from Robitussin, a common DXM-containing cough syrup, and the "robot-like" dissociated state users describe. It produces four distinct plateaus of effects ranging from mild stimulation to complete dissociation and delirium.

How much DXM causes overdose?

Medical emergencies typically occur above 400-600 mg, though individual sensitivity varies based on body weight, tolerance, and other medications. Overdose symptoms can include seizures, severe respiratory depression, dangerous heart rhythms, loss of consciousness, and death. Any overdose is potentially life-threatening - call 911 or poison control immediately.

Can DXM products containing acetaminophen cause liver damage?

Yes, absolutely. Products like Coricidin HBP Cough and some Robitussin formulations combine DXM with acetaminophen. At abuse doses of DXM, the acetaminophen dose becomes dangerously high, causing acute liver damage and potential acute liver failure. This is why single-ingredient DXM products are preferred by abusers, but it also means acetaminophen-containing formulations carry additional severe risks.

What is serotonin syndrome and why is it dangerous with DXM?

Serotonin syndrome develops when DXM is combined with SSRIs, SNRIs, MAOIs, or other serotonergic drugs. Excessive serotonin in the brain causes agitation, confusion, rapid heart rate, high fever, muscle rigidity, and potentially seizures, organ failure, and death. Anyone taking antidepressants or other serotonergic medications must avoid DXM misuse entirely. This combination is life-threatening.

Can I become physically dependent on DXM?

Yes. Chronic DXM abuse causes both psychological and physical dependence. Physical withdrawal symptoms include anxiety, depression, insomnia, muscle aches, and gastrointestinal symptoms. While not as medically dangerous as opioid withdrawal, DXM withdrawal is psychologically difficult and can last 2-3 weeks acutely, with post-acute symptoms persisting months or longer.

Is DXM abuse common in teenagers?

Yes, DXM abuse is a significant problem among adolescents and young adults. According to California Poison Control data, 74.5% of DXM abuse cases involved individuals aged 9-17, with a median age of 16. Peak abuse occurred around 2006 with over 34,000 exposures reported. The easy accessibility of OTC products and lack of age restrictions make DXM a common first substance of abuse for some youth.

Sources

• Dextromethorphan - Poison Control - National Capital Poison Center
• Dextromethorphan Chemical Data - PubChem Database
• Dextromethorphan - Wikipedia
• DXM (Dextromethorphan) - National Drug Intelligence Center, DEA
• Dextromethorphan Toxicity - NCBI Bookshelf (StatPearls)
• Dextromethorphan Abuse - PubMed Central
• Dextromethorphan Abuse Liability and Pharmacology - Expert Opinion on Drug Metabolism & Toxicology
• Dextromethorphan - DrugBank - Therapeutic Targets Database

---

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Call 988 or 1-800-662-4357 for immediate help with substance use or mental health crises.